Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,906 | 3,524 | 11,367 | 9,837 | 1,128 |
| Marketable Securities | 3,175 | 4,141 | 3 | 420 | 0 |
| Other current assets | 0 | 0 | 66 | 0 | 57 |
| TOTAL | $7,112 | $7,681 | $11,572 | $10,402 | $1,427 |
| Non-Current Assets | |||||
| Intangibles | 241 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 59 | 65 | 71 | 88 | 0 |
| TOTAL | $300 | $65 | $71 | $88 | $N/A |
| Total Assets | $7,412 | $7,746 | $11,643 | $10,490 | $1,427 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,584 | 704 | 364 | 418 | 127 |
| TOTAL | $1,656 | $776 | $436 | $490 | $142 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4 |
| Deferred Revenues | 72 | 72 | 72 | 72 | N/A |
| TOTAL | $722 | $794 | $866 | $938 | $4 |
| Total Liabilities | $2,378 | $1,569 | $1,302 | $1,428 | $146 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,484 | 2,844 | 3,159 | 98,672 | 85,177 |
| Common Shares | 0 | 0 | 0 | 0 | 9 |
| Retained earnings | -15,265 | -10,872 | -7,171 | -3,263 | -5,762 |
| Other shareholders' equity | 3 | -477 | 0 | 0 | 0 |
| TOTAL | $5,034 | $6,177 | $10,341 | $9,062 | $1,281 |
| Total Liabilities And Equity | $7,412 | $7,746 | $11,643 | $10,490 | $1,427 |